Durect Competitors and Similar CompaniesClear all
Durect's competitors and similar companies include BTG.
 Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. | ||
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Cupertino, US HQ | |
Employees | Employees 902% increase | Employees 650 |
Financial | ||
Revenue (est.) | Revenue (est.) $2m (FY, 2024) | Revenue (est.) £731.3m (FY, 2019) |
Cost of goods | Cost of goods $78k (FY, 2024) | Cost of goods £221m (FY, 2019) |
Gross profit | Gross profit $2m (FY, 2024) | Gross profit £510.3m (FY, 2019) |
Net income | Net income ($8.3m) (FY, 2024) | Net income £88.3m (FY, 2019) |
For sources of this data, please see the company profile